Staying at the crossroads: Assessment of the potential of serum lithium monitoring in predicting an ideal lithium dose

Revista Brasileira de Psiquiatria

Volumn 30, Issue 3, 2008, Pages 215-221

  Lima, Thiago Zaqueu ^a   Blanco, Miriam Marcela ^a   Dos Santos Jr , Jair Guilherme ^a   Coelho, Carolina Tesone ^a   Mello, Luiz Eugênio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brain, lithium levels; Lithium chloride; Open field test; Serum, lithium levels; Test, anxiety

Indexed keywords

LITHIUM; LITHIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; LITHIUM BLOOD LEVEL; MAZE TEST; NONHUMAN; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; FEMALE; LITHIUM CHLORIDE; MALE; MAZE LEARNING; RATS; RATS, WISTAR;

EID: 54249119534     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000300007     Document Type: Article

References (40)

1. Waring WS. Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status. Basic Clin Pharmacol Toxicol. 2007;100(5):353-5.
2. Chiu CC, Shen WW, Chen KP, Lu ML. Application of the Cockcroft-Gault method to estimate lithium dosage requirement. Psychiatry Clin Neurosci. 2007;61(3):269-74.
3. Hagino OR, Weller EB, Weller RA, Fristad MA. Comparison of lithium dosage methods for preschool- and early school-age children. J Am Acad Child Adolesc Psychiatry. 1998;37(1):60-5.
4. Thase ME. Bipolar depression: diagnostic and treatment considerations. Dev Psychopathol. 2006;18(4):1213-30.
5. Kato T, Inubushi T, Takahashi S. Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. J Clin Psychopharmacol. 1994;14(5):330-5.
6. Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34(4):280-5.
7. Wang PW, Ketter TA. Pharmacokinetics of mood stabilizers and new anticonvulsants. Psychopharmacol Bull. 2002;36(1):44-66.
8. Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature. 2003;423(6938):435-9.
9. Ren M, Senatorov VV, Chen RW, Chuang DM. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Nat Acad Sci USA. 2003;100(10):6210-5.
10. Wada A, Yokoo H, Yanagita T, Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci. 2005;99(4):307-21.
11. Janson CG, Assadi M, Francis J, Bilaniuk L, Shera D, Leone P. Lithium citrate for Canavan disease. Pediatr Neurol. 2005;33(4):235-43.
12. Pilcher HR. Drug research: the ups and downs of lithium. Nature. 2003;425(6954):118-20.
13. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356(9237):1241-2. Erratum in: Lancet. 2000;356(9247):2104.
14. Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM. Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience. 2003;117(1):55-61.
15. Kim JS, Chang MY, Yu IT, Kim JH, Lee SH, Lee YS, Son H. Lithium selectively increases neuronal differentiation of hippocampus neural progenitor cells both in vitro and in vivo. J Neurochem. 2004;89(2):324-36.
16. Linder MW, Keck PE Jr. Standards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1998;44(5):1073-84.
17. Amdisen A. Serum concentration and clinical supervision in monitoring of lithium treatment. Ther Drug Monit. 1980;2(1):73-83.
18. Bartha L, Marksteiner J, Bauer G, Benke T. Persistent cognitive deficits associated with lithium intoxication: a neuropsychological case description. Cortex. 2002;38(5):743-52.
19. Presne C, Fakhouri F, Noel LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 2003;64(2):585-92.
20. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J Psychopharmacol. 2006;20(3):347-55.
21. Frazer A, Mendels J, Brunswick D, London J, Pring M, Ramsey TA, Rybakowski J. Erythrocyte concentrations of the lithium ion: clinical correlates and mechanisms of action. Am J Psychiatry. 1978;135(9):1065-9.
22. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29(3):172-91.
23. Levine S, Saltzman A, Katof B, Meister A, Cooper TB. Lithium distribution in experimental inflammation of brain and spinal cord. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(6):1011-7.
24. Ramaprasad S. Lithium spectroscopic imaging of rat brain at therapeutic doses. Mag Resonance Imaging. 2004;22(5):727-34.
25. Gould TD, Chen G, Manji HK. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology. 2004;29(1):32-8.
26. Curtis KS, Sved AF, Verbalis JG, Stricker EM. Lithium chloride-induced anorexia, but not conditioned taste aversions, in rats with area postrema lesions. Brain Res. 1994;663(1):30-7.
27. Smith DF. Lithium and carbamazepine: effects on learned taste aversion and open field behavior in rats. Pharmacol Biochem Behav. 1983;18(4):483-8.
28. Ossenkopp KP, Eckel LA. Toxin-induced conditioned changes in taste reactivity and the role of the chemosensitive area postrema. Neurosci Biobehav Rev. 1995;19(1):99-108.
29. Parker LA. Taste avoidance and taste aversion: evidence for two different processes. Learn Behav. 2003;31(2):165-72.
30. Tenk CM, Kavaliers M, Ossenkopp KP. Dose response effects of lithium chloride on conditioned place aversions and locomotor activity in rats. Eur J Pharmacol. 2005;515(1-3):117-27.
31. Johnson FN. Lithium effects upon components of activity in rats. Experientia. 1976;32(2):212-4.
32. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS. Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A. 2004;101(11):3973-8.
33. Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon WA Jr., Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci. 2006;26(22):6031-9.
34. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand. 2001;104(3):163-72.
35. Alda M. Method for prediction of serum lithium levels. Biol Psychiatry. 1988;24(2):218-24.
36. Gervasoni N, Zona-Favre MP, Osiek C, Roth L, Bondolfi G, Bertschy G. Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation. Pharmacol Res. 2003;48(6):649-53.
37. Marr MA, Djuric PE, Ritschel WA, Garver DL. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method. Clin Pharm. 1983;2(3):243-8.
38. Naganuma H, Akiyoshi J, Fujii I. Prediction of optimal lithium dosage. J Clin Psychopharmacol. 1988;8(1):66-7.
39. Srisurapanont M, Pratoomsri W, Maneeton N. Evaluation of three simple methods for predicting therapeutic lithium doses. Psychiatry Res. 2000;94(1):83-8.
40. Kato T, Fujii K, Shioiri T, Inubushi T, Takahashi S. Lithium side effects in relation to brain lithium concentration measured by lithium-7 magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(1):87-97.